Glaucoma Quality of Life
Total Page:16
File Type:pdf, Size:1020Kb
Journal of Ophthalmology Glaucoma Quality of Life Lead Guest Editor: Antonio M. Fea Guest Editors: Fritz Hengerer and Leon Au Glaucoma Quality of Life Journal of Ophthalmology Glaucoma Quality of Life Lead Guest Editor: Antonio M. Fea Guest Editors: Fritz Hengerer and Leon Au Copyright © 2017 Hindawi. All rights reserved. This is a special issue published in “Journal of Ophthalmology.” All articles are open access articles distributed under the Creative Com- mons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Monica L. Acosta, New Zealand Vlassis Grigoropoulos, Greece Jesús Pintor, Spain Hee B. Ahn, Republic of Korea Vishal Jhanji, Hong Kong Antonio Queiros, Portugal Luis Amselem, Spain Thomas Klink, Germany Anthony G. Robson, UK Usha P. Andley, USA Naoshi Kondo, Japan Mario R. Romano, Italy S. Ansari-Shahrezaei, Austria Ozlem G. Koz, Turkey Dirk Sandner, Germany Taras Ardan, Czech Republic Hiroshi Kunikata, Japan Ana Raquel Santiago, Portugal F. Arnalich-Montiel, Spain Toshihide Kurihara, Japan Patrik Schatz, Sweden Takayuki Baba, Japan George Kymionis, Greece Kin Sheng Lim, UK Paul Baird, Australia Neil Lagali, Sweden Wisam A. Shihadeh, USA Antonio Benito, Spain Achim Langenbucher, Germany Bartosz Sikorski, Poland Mehmet Borazan, Turkey Van C. Lansingh, Mexico Katsuyoshi Suzuki, Japan Francis Carbonaro, Malta Paolo Lanzetta, Italy S. K. Swamynathan, USA Chi-Chao Chan, USA Theodore Leng, USA Suphi Taneri, Germany Lingyun Cheng, USA Marco Lombardo, Italy C. Tappeiner, Switzerland Chung-Jung Chiu, USA Tamer A. Macky, Egypt S. Charn Beng Teoh, Singapore Daniel C. Chung, USA Edward Manche, USA P. Theodossiadis, Greece Colin Clement, Australia Flavio Mantelli, USA Biju B. Thomas, USA Miguel Cordero-Coma, Spain E. Mencía-Gutiérrez, Spain Lisa Toto, Italy Ciro Costagliola, Italy Marcel Menke, Switzerland Manuel Vidal-Sanz, Spain Vasilios F. Diakonis, USA Lawrence S Morse, USA Gianmarco Vizzeri, USA Priyanka P. Doctor, India Darius M. Moshfeghi, USA David A. Wilkie, USA Michel E. Farah, Brazil Majid M. Moshirfar, USA Suichien Wong, UK Giulio Ferrari, Italy Hermann Mucke, Austria Victoria W Y Wong, Hong Kong Paolo Fogagnolo, Italy Ramon Naranjo-Tackman, Mexico Terri L. Young, USA Joel Gambrelle, France Neville Osborne, UK H. Gon Yu, Republic of Korea M.-A. Gamulescu, Germany Ji-jing Pang, USA Vicente Zanon-Moreno, Spain S. Garcia-Lazaro, Spain Enrico Peiretti, Italy Ian Grierson, UK David P. Piñero, Spain Contents Glaucoma Quality of Life Antonio Maria Fea, Fritz Hengerer, Carlo Lavia, and Leon Au Volume 2017, Article ID 4257151, 2 pages Self-Monitoring Symptoms in Glaucoma: A Feasibility Study of a Web-Based Diary Tool Leanne McDonald, Fiona C. Glen, Deanna J. Taylor, and David P. Crabb Volume 2017, Article ID 8452840, 8 pages Twenty-Four-Hour Variation of Intraocular Pressure in Primary Open-Angle Glaucoma Treated with Triple Eye Drops Yoshinori Itoh, Kenji Nakamoto, Hiroshi Horiguchi, Shumpei Ogawa, Takahiko Noro, Makoto Sato, Tadashi Nakano, Hiroshi Tsuneoka, and Noriko Yasuda Volume 2017, Article ID 4398494, 6 pages A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma Alaa Abdel Sadek Singab, Osama Ali Mohammed, Mohammed Iqbal Hafez Saleem, and Mortada Ahmed Abozaid Volume 2017, Article ID 9241459, 7 pages The Effect of Corneal Refractive Surgery on Glaucoma Vassilios Kozobolis, Aristeidis Konstantinidis, Haris Sideroudi, and G. Labiris Volume 2017, Article ID 8914623, 8 pages Long-Term Clinical Course of Normal-Tension Glaucoma: 20 Years of Experience Sang Wook Jin and Seung Yoon Noh Volume 2017, Article ID 2651645, 6 pages Gradually Then Suddenly? Decline in Vision-Related Quality of Life as Glaucoma Worsens Lee Jones, Susan R. Bryan, and David P. Crabb Volume 2017, Article ID 1621640, 7 pages Eye-Tracking as a Tool to Evaluate Functional Ability in Everyday Tasks in Glaucoma Enkelejda Kasneci, Alex A. Black, and Joanne M. Wood Volume 2017, Article ID 6425913, 10 pages Examining Delay Intervals in the Diagnosis and Treatment of Primary Open Angle Glaucoma in an Egyptian Population and Its Impact on Lifestyle Iman M. Eissa, Nahla B. Abu Hussein, Ahmed E. Habib, and Yasmine M. El Sayed Volume 2016, Article ID 7012826, 6 pages Hindawi Journal of Ophthalmology Volume 2017, Article ID 4257151, 2 pages https://doi.org/10.1155/2017/4257151 Editorial Glaucoma Quality of Life 1 2 1 3 Antonio Maria Fea, Fritz Hengerer, Carlo Lavia, and Leon Au 1Dipartimento di Scienze Chirurgiche-Clinica Oculistica, Università di Torino, Turin, Italy 2Goethe University of Frankfurt, Frankfurt am Main, Germany 3Manchester Royal Eye Hospital, Central Manchester Foundation Trust, Manchester, UK Correspondence should be addressed to Antonio Maria Fea; [email protected] Received 13 June 2017; Accepted 14 June 2017; Published 18 July 2017 Copyright © 2017 Antonio Maria Fea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Growing attention has been given to the quality of life in recognize patients who can benefit from rehabilitation and several fields of medicine. The concept of quality of life evaluate the efficacy of those measures. is not unknown to the glaucoma culture if we recall that the Since the first studies on quality of life in glaucoma, European Glaucoma Society Guidelines state “the goal of several areas of interest have been identified and explored: glaucoma treatment is to maintain the patient’s visual func- (1) determining the symptoms that are more bothersome tion and related quality of life (QoL), at a sustainable cost.” for the patients and correlating them with the stage of Nevertheless in the past, more attention has been given to disease; (2) testing and building better methods to investigate quantitative matters as IOP, visual field, and optic nerve the impact of glaucoma on the QoL; (3) assessing the impact because those were the ones that can be directly modified of glaucoma on mental status; and (4) analyzing the impact and physicians were less interested in qualitative and subjec- of different therapies on the QoL of glaucoma patients. tive measures as the QoL. Measurements of QoL, on the other hand, tend to be time consuming and can be strongly (1) Thanks to recent investigations, we are now aware influenced by other factors (general physical health, psycho- that vision defects in glaucoma patients are not as logical state, personality, relationships, wealth, etc.), which simple as the traditional view of peripheral vision are not necessarily related to the disease itself. loss, but they affect several aspects related to a gener- However, there is no doubt that when the physician pays ally decreased image quality including glare, letters attention to the claims of the patients, he will realize that appearing faded when reading, and needing more most of their questions are related to everyday issues such light. Glaucoma patients gave the higher importance as “will I be able to drive my car? Will I be able to be indepen- to tasks involving central and near vision (reading) dent in my daily tasks within my home? And will I be able to and to mobility outside the home, whereas the most go the supermarket two blocks from my house? Will I have frequent complaints were difficulties related to light- problems reading?” ing and in particular adapting to different levels of The same questions are relevant for insurances and gov- light. Common complaints also included difficulty ernments because the disability caused by any disease will in walking, stair climbing, face recognition, and driv- help determine the level at which the benefits of screening ing. The relative importance of these problems is outweigh costs and decide which patient should be treated correlated to the degree of visual function and to and how aggressive treatment should be. Furthermore, the age of the patient. The correlation coefficients knowing the degree of disability can potentially help to for the lower paracentral and lower peripheral VF increase patient safety with appropriate guidelines, to of the better eye were the highest for several sub- 2 Journal of Ophthalmology scales, such as general vision, near vision, distance among patients without clinically significant visual vision, social function, mental health, role limitation, disabilities. Counseling regarding the generally slow and driving. Although the best correlations were progression rate of the disease may result in a generally found in the visual field of the better eye, decreased burden from depression. the best metric to relate disease severity to disability (4) The impact of new therapies, minimally invasive sur- is still a matter of debate and further work is needed gical procedures, and slow drug-releasing implants in the field. on the patient’s QoL will certainly be a rapid growing (2) QoL assessment traditionally used patient-reported- field of investigation. The research in this field may outcome (PRO) questionnaires. More than 30 potentially guide the researchers to select new thera- vision-specific PRO measures have been developed pies that have minimal effect on the quality of life in the context of glaucoma and can be classified in and the agencies to evaluate the general and eco- three categories: PROs addressing functional status nomic impacts of these new therapies on the glau- related to vision, PROs addressing overall QoL, and coma patients. PROs assessing other factors related to disease and treatment (i.e., symptoms, side effects, adherence, We decided to dedicate this special issue to QoL with satisfaction, and self-efficacy). Several studies failed the aim to shed light on the quality of life of glaucoma fi to demonstrate a correlation between QoL and patients and attract attention of the scienti c community glaucoma severity especially when PROs were not to pursue further investigations leading to a rapid develop- fi specifically designed.